Biotech entity
All 1 tracked stories fall under one category: pharma. Astellas Pharma is most often covered alongside Bioelectronic Medicine Forum, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Astellas Pharma appears in 1 tracked Biotech story from March 5, 2026.
Last mentioned: Mar 5, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Astellas Pharma is most often covered alongside Bioelectronic Medicine Forum, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Astellas Pharma appears in 1 tracked Biotech story from March 5, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Astellas Pharma. Shared-story counts are live from our verified record — not editorial picks.
Keynote Announcement
Jose Carmena announced as keynote for the 2026 Bioelectronic Medicine Forum in NYC.
Astellas Acquisition
Astellas Pharma acquires Iota Biosciences to bolster its 'Rx+' innovation strategy.
Iota Biosciences Founded
Jose Carmena and Michel Maharbiz spin out 'neural dust' technology from UC Berkeley.
Jose Carmena, co-founder of Iota Biosciences, has been named the keynote speaker for the 2026 Bioelectronic Medicine Forum in New York City. The event highlights the accelerating shift toward ultrasound-powered 'neural dust' and minimally invasive neuromodulation therapies.
Astellas Pharma is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
